Showing results (31-40 of 184) with videos related to

Sort By:
Pageof 19
Pharmaceutics|December 19, 2014
Interaction potential of the multitargeted receptor tyrosine kinase inhibitor dovitinib with drug transporters and drug metabolising enzymes assessed in vitroJohanna Weiss, Dirk Theile, Zdenek Dvorak, et al.
Pulmonary Pharmacology & Therapeutics|December 24, 2014
Desmethyl bosentan displays a similar in vitro interaction profile as bosentanJohanna Weiss, Sybille Baumann, Dirk Theile, et al.
Cells|November 27, 2021
Regulation of PXR Function by Coactivator and Corepressor Proteins: Ligand Binding Is Just the BeginningJuan Pablo Rigalli, Dirk Theile, Julie Nilles, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 22, 2012
In vitro identification of the cytochrome P450 isozymes involved in the N-demethylation of the active opioid metabolite nortilidine to bisnortilidineIsabel Wustrow, Klaus-Dieter Riedel, Gerd Mikus, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2010
Interaction potential of etravirine with drug transporters assessed in vitroNadine Cécile Luise Zembruski, Walter Emil Haefeli, Johanna Weiss
Molecular Pharmacology|August 17, 2004
Modulation of cellular cholesterol alters P-glycoprotein activity in multidrug-resistant cellsJoachim Troost, Heike Lindenmaier, Walter Emil Haefeli, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 11, 2026
The striking divergence of ABCB1 mRNA expression and P-glycoprotein protein levels in M1 and M2 macrophages associates with the microRNA miR-21-3p, a regulator of "RNA binding protein, mRNA processing factor"Katharina Hamburg, Johanna Weiss, Julia Carolin Stingl, et al.
Biochemical Pharmacology|July 23, 2009
Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapyDirk Theile, Sina Grebhardt, Walter Emil Haefeli, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 4, 2021
In vitro evidence suggesting that the toll-like receptor 7 and 8 agonist resiquimod (R-848) unlikely affects drug levels of co-administered compoundsDirk Theile, Lelia Wagner, Walter E Haefeli, et al.
Addiction Biology|December 24, 2003
P-glycoprotein modulation by the designer drugs methylenedioxymethamphetamine, methylenedioxyethylamphetamine and paramethoxyamphetamineNahal Ketabi-Kiyanvash, Johanna Weiss, Walter Emil Haefeli, et al.
Pageof 19